Ischemic Heart Disease in the Context of Different Comorbidities

Ischemic heart disease is a cardiovascular condition with very high prevalence worldwide and a major source of morbidity and mortality, especially in the geriatric population. The management of coronary artery disease is one that requires high-level expertise. The presence of comorbidities, usually...

Full description

Saved in:
Bibliographic Details
Other Authors: Costache, Irina-Iuliana (Editor), Mihai, Bogdan-Mircea (Editor), Badescu, Minerva Codruta (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_94544
005 20221206
003 oapen
006 m o d
007 cr|mn|---annan
008 20221206s2022 xx |||||o ||| 0|eng d
020 |a books978-3-0365-5809-7 
020 |a 9783036558103 
020 |a 9783036558097 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-5809-7  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
072 7 |a MJD  |2 bicssc 
100 1 |a Costache, Irina-Iuliana  |4 edt 
700 1 |a Mihai, Bogdan-Mircea  |4 edt 
700 1 |a Badescu, Minerva Codruta  |4 edt 
700 1 |a Costache, Irina-Iuliana  |4 oth 
700 1 |a Mihai, Bogdan-Mircea  |4 oth 
700 1 |a Badescu, Minerva Codruta  |4 oth 
245 1 0 |a Ischemic Heart Disease in the Context of Different Comorbidities 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (242 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Ischemic heart disease is a cardiovascular condition with very high prevalence worldwide and a major source of morbidity and mortality, especially in the geriatric population. The management of coronary artery disease is one that requires high-level expertise. The presence of comorbidities, usually multiple at advanced ages, makes the diagnosis and therapy very challenging. In this setting, the effort of a multidisciplinary team is urgently needed to achieve integrated management of these cases, being the only one capable of leading to the best results for the patient.The purpose of this reprint is to bring together the experience of specialists in treating ischemic heart disease in the presence of major related conditions that require particular modulations of diagnostic and therapeutic interventions. The chapters address difficult areas of interference between ischemic heart disease and frailty, cancer, liver diseases, inflammatory bowel disease and the new SARS-CoV-2 infection. Special consideration is granted to cardiac remodeling and progression to heart failure. Niche topics such as acute coronary syndromes triggered by carbon monoxide poisoning are present as well. The book also contains a particularly interesting chapter dedicated to the genetic substrate of ischemic heart disease, which once again emphasizes the need for a multidisciplinary team approach to this disease.We consider the reprint an excellent source of information for medical practitioners who have to solve complex cases of ischemic heart disease. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
650 7 |a Cardiovascular medicine  |2 bicssc 
653 |a coronary artery disease 
653 |a ischemic heart disease 
653 |a atherosclerosis 
653 |a genetic risk factors 
653 |a heritability 
653 |a polymorphism 
653 |a GWAS 
653 |a PRS 
653 |a COVID-19 
653 |a myocardial ischemia 
653 |a electrocardiography 
653 |a accelerated atherosclerosis 
653 |a coronary spasm 
653 |a coronary thrombosis 
653 |a endothelial dysfunction 
653 |a cancer 
653 |a prevention 
653 |a radiotherapy 
653 |a chemotherapy 
653 |a liver cirrhosis 
653 |a prevalence 
653 |a liver transplantation 
653 |a treatment 
653 |a myocardial injury 
653 |a cytokines 
653 |a biomarkers 
653 |a heart failure 
653 |a left ventricular remodeling 
653 |a myocardial infarction 
653 |a wall stress 
653 |a inflammation 
653 |a neurohormonal activation 
653 |a inflammatory bowel disease 
653 |a ulcerative colitis 
653 |a Crohn's disease 
653 |a cardiovascular risk 
653 |a frailty 
653 |a chronic coronary syndrome 
653 |a elderly 
653 |a acute coronary syndrome 
653 |a carbon monoxide poisoning 
653 |a severity of poisoning 
653 |a cardiotoxicity 
653 |a troponin 
653 |a cardiac dysfunction 
653 |a non-alcoholic fatty liver disease 
653 |a liver-heart axis 
653 |a n/a 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/6379  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/94544  |7 0  |z DOAB: description of the publication